US 8278348
Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof
granted A61PA61P13/00A61P15/08
Quick answer
US patent 8278348 (Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P13/00, A61P15/08, A61P19/08, A61P19/10